Bright Minds Biosciences Inc. Common Stock (DRUG) is a publicly traded Healthcare sector company. As of September 4, 2026, DRUG trades at $65.25 with a market cap of $667.42M and a P/E ratio of 0.00. DRUG moved -3.78% today. Year to date, DRUG is -18.56%; over the trailing twelve months it is +54.26%. Its 52-week range spans $23.18 to $123.75. Analyst consensus is buy with an average price target of $145.01. Rallies surfaces DRUG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
2 analysts cover DRUG: 0 strong buy, 2 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $145.01.
| Metric | Value |
|---|---|
| Price | $65.25 |
| Market Cap | $667.42M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $123.75 |
| 52-Week Low | $23.18 |
| Volume | 86.15K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
2 analysts cover DRUG: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $145.01.